Jazz Pharmaceuticals plc Long-Term Debt, Maturity, after Year Five
Jazz Pharmaceuticals plc (JAZZ) had Long-Term Debt, Maturity, after Year Five of $1.00 billion as of 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2025-02-26
- 2024-12-31: Long-Term Debt, Maturity, after Year Five $1.00B.
- 2023-12-31: Long-Term Debt, Maturity, after Year Five $1.50B.
- 2022-12-31: Long-Term Debt, Maturity, after Year Five $4.10B.
- 2021-12-31: Long-Term Debt, Maturity, after Year Five $4.67B.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2024-12-31 | $1.00B 10-K · filed 2025-02-26 |
| 2023-12-31 | $1.50B 10-K · filed 2024-02-28 |
| 2022-12-31 | $4.10B 10-K · filed 2023-03-01 |
| 2021-12-31 | $4.67B 10-K · filed 2022-03-01 |
| 2019-09-30 | $575.00M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $575.00M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $575.00M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $575.00M 10-K · filed 2019-02-26 |
| 2018-09-30 | $1.09B 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.09B 10-Q · filed 2018-08-07 |
| 2017-12-31 | $575.00M 10-K · filed 2018-02-27 |
| 2017-09-30 | $575.00M 10-Q · filed 2017-11-07 |
| 2016-09-30 | $2.08B 10-Q · filed 2016-11-08 |
| 2016-06-30 | $575.00M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $575.00M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $575.03M 10-K · filed 2016-02-23 |
| 2015-09-30 | $1.18B 10-Q · filed 2015-11-09 |
| 2015-06-30 | $1.26B 10-Q · filed 2015-08-05 |
| 2015-03-31 | $575.13M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $575.15M 10-K · filed 2015-02-24 |
| 2014-09-30 | $575.27M 10-Q · filed 2014-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |